Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
TDOC Stock Forecast 2026-2027
$7.05
Current Price
$1.27B
Market Cap
Buy 7
Hold 19
Sell 0
Wall St Analyst Ratings
Distance to TDOC Price Targets
+41.8%
To High Target of $10.00
-0.7%
To Median Target of $7.00
-29.1%
To Low Target of $5.00
TDOC Price Momentum
-10.9%
1 Week Change
-2.8%
1 Month Change
-3.0%
1 Year Change
+0.7%
Year-to-Date Change
-27.8%
From 52W High of $9.77
+60.2%
From 52W Low of $4.40
📊 TOP ANALYST CALLS
Did TDOC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Teladoc is one of their latest high-conviction picks.
Latest TDOC Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, TDOC has a neutral consensus with a median price target of $7.00 (ranging from $5.00 to $10.00). The overall analyst rating is Buy (7.0/10). Currently trading at $7.05, the median forecast implies a -0.7% downside. This outlook is supported by 7 Buy, 19 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TDOC Analyst Ratings
7
Buy
19
Hold
0
Sell
TDOC Price Target Range
Low
$5.00
Average
$7.00
High
$10.00
Current: $7.05
Latest TDOC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TDOC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 5, 2026 | Citigroup | Daniel Grosslight | Neutral | Maintains | $7.00 |
| Apr 8, 2026 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Mar 26, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Mar 13, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| Mar 10, 2026 | Deutsche Bank | Buy | Upgrade | $N/A | |
| Mar 3, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Mar 3, 2026 | Oppenheimer | Outperform | Maintains | $N/A | |
| Feb 26, 2026 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Feb 26, 2026 | Leerink Partners | Market Perform | Maintains | $N/A | |
| Feb 26, 2026 | TD Cowen | Hold | Maintains | $N/A | |
| Feb 26, 2026 | BMO Capital | Market Perform | Maintains | $N/A | |
| Feb 26, 2026 | Piper Sandler | Overweight | Reiterates | $N/A | |
| Feb 26, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Feb 26, 2026 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Feb 26, 2026 | Stifel | Hold | Maintains | $N/A | |
| Jan 9, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Dec 9, 2025 | Barclays | Equal-Weight | Initiates | $N/A | |
| Nov 25, 2025 | B of A Securities | Neutral | Maintains | $N/A | |
| Nov 13, 2025 | BMO Capital | Market Perform | Initiates | $N/A | |
| Oct 30, 2025 | Evercore ISI Group | In-Line | Maintains | $N/A |
Teladoc Health Inc. (TDOC) Competitors
The following stocks are similar to Teladoc based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Teladoc Health Inc. (TDOC) Financial Data
Teladoc Health Inc. has a market capitalization of $1.27B with a P/E ratio of -6.2x. The company generates $2.51B in trailing twelve-month revenue with a -6.8% profit margin.
Revenue growth is -2.5% quarter-over-quarter, while maintaining an operating margin of -7.9% and return on equity of -12.4%.
Valuation Metrics
Market Cap
$1.27B
Enterprise Value
$1.56B
P/E Ratio
-6.2x
PEG Ratio
0.1x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
-2.5%
Gross Margin
+67.8%
Operating Margin
-7.9%
Net Margin
-6.8%
EPS Growth
-2.5%
Financial Health
Cash/Price Ratio
+59.0%
Current Ratio
2.8x
Debt/Equity
77.7x
ROE
-12.4%
ROA
-3.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Teladoc Health Inc. (TDOC) Business Model
About Teladoc Health Inc.
What They Do
Provides virtual healthcare services worldwide.
Business Model
The company operates through two main segments: Integrated Care and BetterHelp. It generates revenue by offering a wide range of virtual medical services, including general medical care, specialty consultations, and mental health services, along with AI-enabled solutions and partnerships for connected care.
Additional Information
Founded in 2002 and headquartered in New York, Teladoc Health partners with health plans, employers, and health systems to deliver comprehensive, personalized care. Its Prism care delivery platform facilitates coordination of care across both digital and community providers.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
4,620
CEO
Mr. Charles Divita III, CPA
Country
United States
IPO Year
2015
Website
www.teladochealth.comTeladoc Health Inc. (TDOC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Here's Why Investors Should Hold on to Teladoc Health Stock for Now
TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.
Jun 05, 2026
By Zacks Equity Research
Analyst Blog
Teladoc (TDOC) Up 23.9% Since Last Earnings Report: Can It Continue?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
May 29, 2026
By Zacks Equity Research
Realtime BLOG
Hims & Hers Expands Integrated Health Access via Platform Expansion
HIMS expands its integrated telehealth ecosystem with a new weight-loss membership and a planned Eucalyptus acquisition to broaden virtual care.
May 29, 2026
By Debanjana Dey
Analyst Blog
Latest News
Quick Summary
Shareholders are encouraged to contact the firm quickly to enforce their rights, with legal fees covered on a contingent basis, meaning no upfront costs are required.
Why It Matters
The excerpt indicates potential legal issues for the firm, which could affect stock value and investor confidence. Prompt action may impact shareholder rights and financial outcomes.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
TDOC shows growth from Integrated Care and international expansion, along with cost reductions. However, challenges include weaknesses in BetterHelp and ongoing financial losses.
Why It Matters
TDOC's growth in integrated care and international markets signals potential revenue increases, while cost-cutting measures may improve margins. However, challenges from BetterHelp and ongoing losses could impact profitability.
Source: Zacks Investment Research
Market Sentiment:
Positive
A Major Catalyst Is Emerging For REITs
4 days ago
Quick Summary
Tech stocks are at risk from AI disruption, while REITs benefit from the AI Immunity Trade. Hard assets may increase in value due to advancements in AI.
Why It Matters
Tech stocks may decline due to AI disruption, while REITs could gain as hard assets appreciate. Shifts in asset values impact investment strategies and portfolio allocations.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Teladoc Health (NYSE: TDOC) has partnered with Walmart to offer its virtual care services through Walmart's Better Care Services platform, enhancing access for customers.
Why It Matters
Teladoc's partnership with Walmart enhances its market reach and customer base, potentially driving revenue growth and improving competitive positioning in the virtual care sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Teladoc Health (TDOC) has partnered with Walmart to provide virtual urgent care, dermatology, and nutrition services, enhancing affordable telehealth access across the U.S.
Why It Matters
TDOC's partnership with Walmart enhances its market reach and service offerings, potentially increasing revenue and user engagement in the growing telehealth sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Teladoc (TDOC) recently reported earnings, and investors are now looking ahead to potential developments for the stock.
Why It Matters
Teladoc's recent earnings report sets the tone for future performance and investor sentiment, influencing stock volatility and potential growth or decline in value.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About TDOC Stock
What is Teladoc Health Inc.'s (TDOC) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Teladoc Health Inc. (TDOC) has a median price target of $7.00. The highest price target is $10.00 and the lowest is $5.00.
Is TDOC stock a good investment in 2026?
According to current analyst ratings, TDOC has 7 Buy ratings, 19 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.05. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TDOC stock?
Wall Street analysts predict TDOC stock could reach $7.00 in the next 12 months. This represents a -0.7% decrease from the current price of $7.05. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Teladoc Health Inc.'s business model?
The company operates through two main segments: Integrated Care and BetterHelp. It generates revenue by offering a wide range of virtual medical services, including general medical care, specialty consultations, and mental health services, along with AI-enabled solutions and partnerships for connected care.
What is the highest forecasted price for TDOC Teladoc Health Inc.?
The highest price target for TDOC is $10.00 from at , which represents a 41.8% increase from the current price of $7.05.
What is the lowest forecasted price for TDOC Teladoc Health Inc.?
The lowest price target for TDOC is $5.00 from at , which represents a -29.1% decrease from the current price of $7.05.
What is the overall TDOC consensus from analysts for Teladoc Health Inc.?
The overall analyst consensus for TDOC is neutral. Out of 4 Wall Street analysts, 7 rate it as Buy, 19 as Hold, and 0 as Sell, with a median price target of $7.00.
How accurate are TDOC stock price projections?
Stock price projections, including those for Teladoc Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 8, 2026 3:58 AM UTC